Management of atrial fibrillation and concomitant coronary artery disease

Continuing Cardiology Education Pub Date : 2017-07-11 DOI:10.1002/cce2.55

R. I. R. Martin, M. G. D. Bates

{"title":"Management of atrial fibrillation and concomitant coronary artery disease","authors":"R. I. R. Martin, M. G. D. Bates","doi":"10.1002/cce2.55","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <p>Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and associated with significant morbidity and mortality. Coronary artery disease (CAD) frequently coexists with AF, and management of these associated conditions can be challenging. Bleeding risks of different combinations of evidence-based antithrombotic regimes need to be considered and the effects of different medical therapies for AF or CAD may impact on the other condition. This article reviews the current guidance and consensus statements of the ESC on the management of AF and CAD. The principles of AF management in the context of CAD are considered including upstream therapies to prevent AF, early identification, and antithrombotic risk assessment, and symptomatic rate and rhythm control strategies. Specific scenarios and an illustrative case are discussed to highlight clinical relevance.</p>\n </section>\n \n <section>\n \n <p><b>Answer questions and earn CME:</b> https://wileyhealthlearning.com/Activity2/5381990/Activity.aspx</p>\n </section>\n </div>","PeriodicalId":100331,"journal":{"name":"Continuing Cardiology Education","volume":"3 2","pages":"47-55"},"PeriodicalIF":0.0000,"publicationDate":"2017-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/cce2.55","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Continuing Cardiology Education","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cce2.55","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 6

Abstract

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and associated with significant morbidity and mortality. Coronary artery disease (CAD) frequently coexists with AF, and management of these associated conditions can be challenging. Bleeding risks of different combinations of evidence-based antithrombotic regimes need to be considered and the effects of different medical therapies for AF or CAD may impact on the other condition. This article reviews the current guidance and consensus statements of the ESC on the management of AF and CAD. The principles of AF management in the context of CAD are considered including upstream therapies to prevent AF, early identification, and antithrombotic risk assessment, and symptomatic rate and rhythm control strategies. Specific scenarios and an illustrative case are discussed to highlight clinical relevance.

Answer questions and earn CME: https://wileyhealthlearning.com/Activity2/5381990/Activity.aspx

Abstract Image

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

房颤及伴发冠状动脉疾病的处理

心房颤动(AF)是最常见的持续性心律失常，具有显著的发病率和死亡率。冠状动脉疾病(CAD)经常与房颤共存，这些相关疾病的管理可能具有挑战性。需要考虑不同循证抗血栓治疗方案组合的出血风险，并且房颤或CAD的不同药物治疗效果可能会影响其他疾病。本文回顾了ESC关于AF和CAD管理的当前指南和共识声明。在冠心病背景下，房颤管理的原则被认为包括预防房颤的上游治疗、早期识别、抗血栓风险评估、症状率和节律控制策略。具体的情况和说明性的情况下，讨论强调临床相关性。回答问题并获得CME: https://wileyhealthlearning.com/Activity2/5381990/Activity.aspx

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Continuing Cardiology Education

自引率

0.00%

发文量

期刊最新文献

Issue Information Myocardial perfusion SPECT and SPECT/CT in interventional cardiology Abdominal aortic aneurysm: screening and management Pulmonary arterial hypertension in congenital heart disease Current knowledge on very late stent thrombosis